ClinicalTrials.govpublic full text
Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer
stage iii breast cancer (t0n2, t1n2, t2n2, t3n1, 2 or t4), stage iib breast cancer (t3n0), interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 843180
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.